AIZ
78
2
BA
47
4
BF.B
48
-2
FOX
68
2
LNC
75
2
CHRW
82
3
MS
74
5
STX
69
2
QCOM
45
2
CNX
49
3
ADT
50
2
AES
47
-3
DHR
66
2
AVY
47
-7
HD
28
-4
CTAS
40
-2
LLY
71
3
ZION
71
2
ROK
47
4
ED
37
-6
AIZ
78
2
BA
47
4
BF.B
48
-2
FOX
68
2
LNC
75
2
CHRW
82
3
MS
74
5
STX
69
2
QCOM
45
2
CNX
49
3
ADT
50
2
AES
47
-3
DHR
66
2
AVY
47
-7
HD
28
-4
CTAS
40
-2
LLY
71
3
ZION
71
2
ROK
47
4
ED
37
-6
Financhill
Back

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Buy
75

IVOV
Vanguard S&P Mid-Cap 400 Value Index Fund ETF

Last Price:
$104.11
Seasonality Move:
4.79%
Sell
46

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$112.11
Seasonality Move:
-13.08%
Buy
75
Vanguard S&P Mid-Cap 400 Value Index Fund ETF (IVOV) is a Buy

Is Vanguard S&P Mid-Cap 400 Value Index Fund ETF a Buy, Sell or Hold?

  • The current Vanguard S&P Mid-Cap 400 Value Index Fund ETF [IVOV] share price is $104.16. The Score for IVOV is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • IVOV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Rhythm Pharmaceuticals, Inc. (RYTM) is a Sell

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $112.14. The Score for RYTM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IVOV Stock Price Chart

What is Vanguard S&P Mid-Cap 400 Value Index Fund ETF's stock price today?

  • The Vanguard S&P Mid-Cap 400 Value Index Fund ETF share price today is $104.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVOV is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $112.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

IVOV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.07 Buy
Relative Strength Index (14 RSI): 60.91 Buy
Chaikin Money Flow: 7215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.04 - 104.2) Buy
Bollinger Bands (100): (98 - 102.42) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 21.04 Buy
Relative Strength Index (14 RSI): 57.33 Buy
Chaikin Money Flow: -397876 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.55 - 111.41) Buy
Bollinger Bands (100): (95.71 - 108.65) Buy

IVOV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.14 Buy
20-day SMA: 102.69 Buy
50-day SMA: 100.74 Buy
200-day SMA: 96.35 Buy
8-day EMA: 103.7 Buy
20-day EMA: 102.7 Buy
50-day EMA: 101.35 Buy
200-day EMA: 98.1 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.08 Buy
20-day SMA: 107.87 Buy
50-day SMA: 106.41 Buy
200-day SMA: 83.22 Buy
8-day EMA: 59.27 Buy
20-day EMA: 29.03 Buy
50-day EMA: 12.66 Buy
200-day EMA: 3.31 Buy

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Earnings Growth & IVOV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):